Protocol No
INF-ABBVIE-M19-965-HIV
Phase
II
Summary
This project is being done to learn if budigalimab and/or ABBV-382 can help the body control the HIV viral load after ART has been stopped.
Description
Abbvie M19-965 HIV study
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov